(in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
---|---|---|---|---|
Current assets | ||||
Cash | $941 | $554 | $737 | $1473 |
Short term investments | ||||
Net receivables | $5398 | $7713 | $8595 | $6009 |
Inventory | $6336 | $5169 | $6062 | $9852 |
Total current assets | $14170 | $14092 | $15996 | $18271 |
Long term investments | $736 | $731 | $708 | $686 |
Property, plant & equipment | $22461 | $22150 | $21920 | $21832 |
Goodwill & intangible assets | ||||
Total noncurrent assets | ||||
Total investments | ||||
Total assets | $52749 | $52229 | $53926 | $56592 |
Current liabilities | ||||
Accounts payable | $5477 | $6615 | $9284 | $10497 |
Deferred revenue | ||||
Short long term debt | $2654 | $4659 | $3267 | $4864 |
Total current liabilities | $12121 | $11312 | $12737 | $15475 |
Long term debt | $9912 | $10328 | $10359 | $10390 |
Total noncurrent liabilities | ||||
Total debt | ||||
Total liabilities | $27548 | $27033 | $28468 | $31287 |
Shareholders' equity | ||||
Retained earnings | $11531 | $11636 | $11823 | $11660 |
Other shareholder equity | -$251 | -$359 | -$280 | -$339 |
Total shareholder equity | $25201 | $25196 | $25458 | $25305 |
(in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Jan 2022 | 31 Dec 2020 |
---|---|---|---|---|
Current assets | ||||
Cash | $941 | $775 | $428 | $2829 |
Short term investments | $71 | $79 | ||
Net receivables | $5398 | $6194 | $5366 | $3581 |
Inventory | $6336 | $7632 | $6328 | $4930 |
Total current assets | $14170 | $16342 | $13846 | $11470 |
Long term investments | $736 | $843 | $703 | $562 |
Property, plant & equipment | $22461 | $21767 | $20016 | $19660 |
Goodwill & intangible assets | ||||
Total noncurrent assets | $35722 | |||
Total investments | ||||
Total assets | $52749 | $54586 | $49954 | $47192 |
Current liabilities | ||||
Accounts payable | $5477 | $11291 | $787 | $4415 |
Deferred revenue | ||||
Short long term debt | $2654 | $2989 | $2391 | $422 |
Total current liabilities | $12121 | $14280 | $12443 | $8480 |
Long term debt | $9912 | $8939 | $8455 | $10938 |
Total noncurrent liabilities | $16347 | |||
Total debt | ||||
Total liabilities | $27548 | $28768 | $26302 | $24827 |
Shareholders' equity | ||||
Retained earnings | $11531 | $11928 | $8192 | $6606 |
Other shareholder equity | -$251 | -$391 | -$146 | -$83 |
Total shareholder equity | $25201 | $25863 | $23699 | $22365 |
(in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
---|---|---|---|---|
Revenue | ||||
Total revenue | $5404 | $5368 | $11402 | $5908 |
Cost of revenue | $3636 | $3741 | $8236 | $3995 |
Gross Profit | $1768 | $1627 | $3166 | $1913 |
Operating activities | ||||
Research & development | ||||
Selling, general & administrative | $1015 | $992 | $1072 | $930 |
Total operating expenses | $5030 | $4910 | $9549 | $4969 |
Operating income | $374 | $458 | $1853 | $939 |
Income from continuing operations | ||||
EBIT | ||||
Income tax expense | -$96 | $97 | $476 | $193 |
Interest expense | -$213 | -$206 | -$204 | -$170 |
Net income | ||||
Net income | $172 | $75 | $440 | $571 |
Income (for common shares) | $172 | $75 | $440 | $571 |
(in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
---|---|---|---|---|
Revenue | ||||
Total revenue | $28082 | $37012 | $26861 | $20908 |
Cost of revenue | $19608 | $21588 | $17452 | $15755 |
Gross Profit | $8474 | $15424 | $9409 | $5153 |
Operating activities | ||||
Research & development | $122 | $69 | ||
Selling, general & administrative | $4009 | $4050 | $3826 | $2868 |
Total operating expenses | $24604 | $27172 | $22015 | $20025 |
Operating income | $3478 | $9840 | $4846 | $883 |
Income from continuing operations | ||||
EBIT | ||||
Income tax expense | $670 | $2559 | $989 | -$77 |
Interest expense | -$793 | -$484 | -$479 | -$55 |
Net income | ||||
Net income | $1258 | $7660 | $3153 | $459 |
Income (for common shares) | $1258 | $7660 | $3153 | $459 |
(in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
---|---|---|---|---|
Net income | $172 | $75 | $440 | $571 |
Operating activities | ||||
Depreciation | $565 | $552 | $556 | $496 |
Business acquisitions & disposals | ||||
Stock-based compensation | ||||
Total cash flows from operations | $4150 | -$469 | $2243 | -$858 |
Investing activities | ||||
Capital expenditures | -$731 | -$567 | -$721 | -$450 |
Investments | ||||
Total cash flows from investing | -$733 | -$673 | -$858 | -$694 |
Financing activities | ||||
Dividends paid | -$262 | -$261 | -$263 | -$246 |
Sale and purchase of stock | $1 | $1 | -$147 | -$869 |
Net borrowings | -$2781 | $1236 | -$1705 | $3269 |
Total cash flows from financing | -$3042 | $976 | -$2124 | $2129 |
Effect of exchange rate | $14 | -$87 | -$52 | |
Change in cash and equivalents | $387 | -$183 | -$736 | $572 |
(in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
---|---|---|---|---|
Net income | $1258 | $7660 | $3153 | $459 |
Operating activities | ||||
Depreciation | $2169 | $1644 | $1637 | $1989 |
Business acquisitions & disposals | ||||
Stock-based compensation | ||||
Total cash flows from operations | $5066 | $8110 | $3886 | $3323 |
Investing activities | ||||
Capital expenditures | -$2465 | -$2227 | -$1549 | |
Investments | ||||
Total cash flows from investing | -$2958 | -$2901 | -$1807 | -$1204 |
Financing activities | ||||
Dividends paid | -$1032 | -$1031 | -$1045 | -$1030 |
Sale and purchase of stock | -$1014 | -$4352 | -$835 | -$160 |
Net borrowings | $19 | $672 | -$1102 | -$134 |
Total cash flows from financing | -$2061 | -$4731 | -$3003 | -$1339 |
Effect of exchange rate | -$91 | -$31 | -$42 | $3 |
Change in cash and equivalents | $40 | $402 | -$955 | $783 |
Natixis Advisors L.P. Boosts Stake in Nutrien Ltd. (NYSE:NTR)
ETF DAILY NEWS
4 Mar 2024
|
Invesco Ltd. Grows Position in Nutrien Ltd. (NYSE:NTR)
ETF DAILY NEWS
1 Mar 2024
|
Top Stock Reports for Costco, Walt Disney & AstraZeneca
Zacks via Yahoo Finance
29 Feb 2024
|
Nutrien (NTR) Declares TSX Clearance of Shares Buyback Program
Zacks via Yahoo Finance
29 Feb 2024
|
Piper Sandler downgrades Nutrien stock on weak grain pricing outlook By Investing.com
Investing.com
29 Feb 2024
|
Piper Sandler downgrades Nutrien stock on weak grain pricing outlook
Investing.com
29 Feb 2024
|
Nutrien to buy back up to 5% of shares in repurchase plan
Investing.com
27 Feb 2024
|
Nutrien (NTR) Ups Quarterly Dividend, Announces Share Buyback
Zacks via Yahoo Finance
26 Feb 2024
|
Hsbc Holdings PLC Lowers Stake in Nutrien Ltd. (NYSE:NTR)
ETF DAILY NEWS
25 Feb 2024
|
Nutrien Target of Unusually Large Options Trading (NYSE:NTR)
ETF DAILY NEWS
24 Feb 2024
|
Market cap | $35.99B |
---|---|
Enterprise value | N/A |
Shares outstanding | 494.55M |
Revenue | $28.08B |
---|---|
EBITDA | N/A |
EBIT | N/A |
Net Income | $1.26B |
Revenue Q/Q | -25.86% |
Revenue Y/Y | -24.13% |
P/E ratio | 28.61 |
---|---|
EV/Sales | N/A |
EV/EBITDA | N/A |
EV/EBIT | N/A |
P/S ratio | 1.28 |
P/B ratio | 1.41 |
Book/Share | 51.46 |
Cash/Share | 1.90 |
EPS | $2.54 |
---|---|
ROA | 2.34% |
ROE | 4.97% |
Debt/Equity | 1.09 |
---|---|
Net debt/EBITDA | N/A |
Current ratio | 1.17 |
Quick ratio | 0.65 |